Rmpl Pharma LLP Lenalidomide Export Data — India (DGFT 2022–2026)

Name: Rmpl Pharma LLP Lenalidomide Export Records India — #10 Exporter, 82 Shipments, $145.7K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Lenalidomide

India Pharmaceutical Trade Intelligence

$883.1M237 Suppliers122 CountriesHS 30049049

ExportsIndia → UNITED STATES96.7%India → JAPAN0.6%

ImportsUNITED STATES → India$1.6M SWITZERLAND → India$1.3M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: SUN PHARMACEUTICAL

Rmpl Pharma LLP — Lenalidomide Exporter #10 | $145.7K Trade Value | TransData Nexus | TransData Nexus

Rmpl Pharma LLP — Lenalidomide Exporter Profile

Indian Pharmaceutical Exporter · #10 for Lenalidomide · $145.7K export value · DGFT Verified

Rmpl Pharma LLP is the #10 Indian exporter of Lenalidomide with $145.7K in export value and 82 verified shipments. Rmpl Pharma LLP holds a 0.0% market share in Lenalidomide exports across 10 countries. The company exports 13 pharmaceutical products worth $438.6K across 3 therapeutic categories.

Rmpl Pharma LLP — Lenalidomide Export Profile: Buyers & Destinations

Rmpl Pharma LLP Lenalidomide export treemap — buyers and destination countries | TransData Nexus

Where Does Rmpl Pharma LLP Export Lenalidomide?

Country	Value	Shipments	Share
SAUDI ARABIA	$107.5K	18	73.7%
UNITED ARAB EMIRATES	$18.3K	17	12.5%
TURKEY	$9.5K	19	6.5%
TANZANIA	$4.1K	5	2.8%
LEBANON	$3.8K	7

Who Are the Top Buyers of Lenalidomide from Rmpl Pharma LLP?

Buyer	Country	Value	Orders
TO THE ORDER OF INVOICE RAISED TO	TURKEY	$87.1K	45
TO THE ORDER	SAUDI ARABIA	$47.1K	6
TO THE ORDER OF INVOICE	UNITED ARAB EMIRATES	$8.6K	20
INVOICE RAISED TO	UGANDA	$1.7K	6

Rmpl Pharma LLP supplies Lenalidomide to 4 buyers globally. The largest buyer is TO THE ORDER OF INVOICE RAISED TO (TURKEY), followed by TO THE ORDER (SAUDI ARABIA) and TO THE ORDER OF INVOICE (UNITED ARAB EMIRATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Lenalidomide Formulations Does Rmpl Pharma LLP Export?

Product Description / Formulation	Value	Shipments
VELIMIDE 25MG 30CAP LENALIDOMIDE 94	$15.6K	1
VELIMIDE 25MG 30CAP LENALIDOMIDE 45	$15.0K	2
VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (673 PACKX30=20190 CAPS)	$10.9K	1
VELIMIDE 10MG 30CAP LENALIDOMIDE 4	$10.8K	2
VELIMIDE 25MG (LENALIDOMIDE) (500 PACKX3	$8.2K	1
VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (43	$7.3K	1
VELIMIDE 10MG (30CAP) (LENALIDOMIDE) (583 PACKX30=17490 CAPS)	$6.9K	1
VELIMIDE 25MG (30CAP) (LENALIDOMIDE) (416 PACKX30=12480 CAPS)	$6.8K	1
LENALID 10MG (30CAP) (LENALIDOMIDE) (15	$6.1K	1
VELIMIDE 10MG (LENALIDOMIDE) (500 PACKX	$6.0K	1

Rmpl Pharma LLP exports 69 distinct Lenalidomide formulations including tablets, capsules, syrups, and combination drugs. The top formulation is VELIMIDE 25MG 30CAP LENALIDOMIDE 94 with 1 shipments worth $15.6K.

How Does Rmpl Pharma LLP Compare to Nearest Lenalidomide Exporters?

Exporters ranked immediately above and below #10 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
8	DR REDDY S LABORATORIES LIMITED	$150.0K	3	2	$50.0K
9	SP ACCURE LABS PRIVATE LIMITED	$149.5K	7	2	$21.4K
10	RMPL PHARMA LLP ★	$145.7K	82	10	$1.8K
11	MYLAN LABORATORIES LIMITED	$133.2K	20	6	$6.7K
12	BETA DRUGS LIMITED	$110.3K	66	10	$1.7K

Rmpl Pharma LLP ranks #10 among 237 Indian Lenalidomide exporters. Average shipment value of $1.8K compared to the market average of $128.1K. The closest competitors by value are DR REDDY S LABORATORIES LIMITED and SP ACCURE LABS PRIVATE LIMITED.

Which Indian Ports Ship Lenalidomide Exports?

Port	Shipments	% Share
SAHAR AIR CARGO ACC (INBOM4)	740	27.2%
SAHAR AIR	688	25.3%
DELHI AIR CARGO ACC (INDEL4)	187	6.9%
Bombay Air	180	6.6%
DELHI AIR	140	5.1%
Bombay Air Cargo	88	3.2%
HYDERABAD ACC (INHYD4)	78	2.9%
HYDERABAD AIR	68	2.5%

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Lenalidomide shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Rmpl Pharma LLP matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 82 individual customs records matching Rmpl Pharma LLP exporting Lenalidomide, covering 69 formulations to 10 countries via 4 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 122+ countries, 557+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Lenalidomide

Lenalidomide

Rmpl Pharma LLP — Lenalidomide Exporter Profile

Rmpl Pharma LLP — Lenalidomide Export Profile: Buyers & Destinations

Where Does Rmpl Pharma LLP Export Lenalidomide?

Who Are the Top Buyers of Lenalidomide from Rmpl Pharma LLP?

What Is India's Total Lenalidomide Export Value and How Much Does Rmpl Pharma LLP Contribute?

What Is the Average Shipment Value for Rmpl Pharma LLP's Lenalidomide Exports?

How Does Rmpl Pharma LLP Compare to Other Indian Lenalidomide Exporters?

What Lenalidomide Formulations Does Rmpl Pharma LLP Export?

How Does Rmpl Pharma LLP Compare to Nearest Lenalidomide Exporters?

Which Indian Ports Ship Lenalidomide Exports?

What Other Advanced Oncology Products Does Rmpl Pharma LLP Export?

About Rmpl Pharma LLP

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Lenalidomide Export Data from Rmpl Pharma LLP

Lenalidomide Stats

Company Overview

Top Products by Rmpl Pharma LLP

Related Analysis

Need Detailed Export Data?

Data Source